23andMe Holding Co. (MEHCQ)
OTCMKTS · Delayed Price · Currency is USD
4.580
-0.170 (-3.58%)
Aug 1, 2025, 4:00 PM EDT
23andMe Holding Co. Market Cap
23andMe Holding Co. has a market cap or net worth of $126.69 million as of August 1, 2025. Its market cap has decreased by -50.58% in one year.
Market Cap
126.69M
Enterprise Value
95.96M
Revenue
189.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.58
Market Cap Chart
Since November 23, 2020, 23andMe Holding Co.'s market cap has decreased from 622.97M to 126.69M, a decrease of -79.66%. That is a compound annual growth rate of -28.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 130.82M | 55.80% |
| Dec 31, 2024 | 83.97M | -80.81% |
| Dec 29, 2023 | 437.66M | -55.52% |
| Dec 30, 2022 | 983.85M | -67.98% |
| Dec 31, 2021 | 3.07B | 322.89% |
| Dec 31, 2020 | 726.59M | 16.63% |
| Nov 23, 2020 | 622.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 396.28M |
| CytoDyn | 371.08M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 361.28M |